Similar companies
Income Statement (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Revenue | 462M | 37.2% |
| Gross Profit | 109M | 15.9% |
| Cost of Revenue | 353M | 45.4% |
| Operating expense | 110M | 4.5% |
| Net Income | -1.3M | 94.2% |
| EBITDA | -810,000 | 96.2% |
Balance Sheet (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Total Assets | 584M | 0.5% |
| Total Liabilities | 248M | 3.4% |
| Total Equity | 336M | 1.5% |
| Shares Outstanding | 497M | 1.1% |
Cash Flow (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Cash from operations | -16M | 81% |
| Cash from financing | -32M | 416.9% |
EPS
Financial Highlights for Clover Health in Q1 '25
Clover Health reported a revenue of 462M, which is a 37.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 109M, marking a 15.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 353M, a 45.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 110M, showing a -4.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -1.3M, showing a 94.2% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -810,000, showing a 96.2% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Clover Health with growth in revenue, gross profit, and net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
